Adam Sinding Steensberg
Chief Executive Officer chez ZEALAND PHARMA A/S
Fortune : 4 M $ au 31/03/2024
Profil
Adam Sinding Steensberg is currently the President & Chief Executive Officer at Zealand Pharma A since 2022.
He is also currently serving as the Chief Executive Officer at The Danish Business Authority since 2019.
Additionally, he holds the position of Chairman at Cessatech A since 2021 and is an Independent Director at the same company since 2020.
Furthermore, he is a Director at Dansk Biotek.
In his former positions, Dr. Steensberg worked as a Medical Director at Novo Nordisk A, a Director at Beta Bionics, Inc., and as a Clinician at Rigshospitalet.
Dr. Steensberg obtained a doctorate degree from the University of Copenhagen.
He also holds an MBA from the International Institute for Management Development, which he received in 2015.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ZEALAND PHARMA A/S
0,07% | 31/12/2023 | 41 143 ( 0,07% ) | 4 M $ | 31/03/2024 |
Postes actifs de Adam Sinding Steensberg
| Sociétés | Poste | Début |
|---|---|---|
| ZEALAND PHARMA A/S | Chief Executive Officer | 30/03/2022 |
| CESSATECH A/S | Director/Board Member | 01/01/2020 |
| The Danish Business Authority | Chief Executive Officer | 01/03/2019 |
Dansk Biotek
 Dansk Biotek Miscellaneous Commercial ServicesCommercial Services Dansk Biotek is an industry association for biotech companies with promoting the biotechnological research, development and production in taking care of corporate interests in this regard, both nationally and internationally. The company was founded in 1987 and is headquartered in Copenhagen, Denmark. | Director/Board Member | - |
Anciens postes connus de Adam Sinding Steensberg
| Sociétés | Poste | Fin |
|---|---|---|
Rigshospitalet
 Rigshospitalet Hospital/Nursing ManagementHealth Services Rigshospitalet is a highly specialized hospital in Denmark that ensures all patients in Denmark have a treatment offer, no matter how rare or complicated their illness is. The hospital is located on Blegdamsvej and in Glostrup. Rigshospitalet prioritizes research and achieves and disseminates results through extensive national and international cooperation. The hospital has subsidiaries in Denmark. | Corporate Officer/Principal | - |
Beta Bionics, Inc.
 Beta Bionics, Inc. Medical SpecialtiesHealth Technology Beta Bionics, Inc. operates a medical technology company leveraging lifelong, machine-learning, artificial intelligence to develop and commercialize the autonomous bionic pancreas. The company was founded by Edward R. Damiano in October 21, 2015 and is headquartered in Boston, MA. | Director/Board Member | - |
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
Formation de Adam Sinding Steensberg
| University of Copenhagen | Doctorate Degree |
| International Institute for Management Development | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| ZEALAND PHARMA A/S | Health Technology |
| CESSATECH A/S | Health Technology |
| Entreprise privées | 4 |
|---|---|
Dansk Biotek
Dansk Biotek Miscellaneous Commercial ServicesCommercial Services Dansk Biotek is an industry association for biotech companies with promoting the biotechnological research, development and production in taking care of corporate interests in this regard, both nationally and internationally. The company was founded in 1987 and is headquartered in Copenhagen, Denmark. | Commercial Services |
Rigshospitalet
Rigshospitalet Hospital/Nursing ManagementHealth Services Rigshospitalet is a highly specialized hospital in Denmark that ensures all patients in Denmark have a treatment offer, no matter how rare or complicated their illness is. The hospital is located on Blegdamsvej and in Glostrup. Rigshospitalet prioritizes research and achieves and disseminates results through extensive national and international cooperation. The hospital has subsidiaries in Denmark. | Health Services |
Beta Bionics, Inc.
Beta Bionics, Inc. Medical SpecialtiesHealth Technology Beta Bionics, Inc. operates a medical technology company leveraging lifelong, machine-learning, artificial intelligence to develop and commercialize the autonomous bionic pancreas. The company was founded by Edward R. Damiano in October 21, 2015 and is headquartered in Boston, MA. | Health Technology |
| The Danish Business Authority | Government |
